A detailed history of Jane Street Group, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 84,039 shares of NUVB stock, worth $221,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,039
Previous 297,329 71.74%
Holding current value
$221,022
Previous $868,000 77.76%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.3 - $3.83 $490,566 - $816,900
-213,290 Reduced 71.74%
84,039 $193,000
Q2 2024

Aug 14, 2024

BUY
$2.58 - $3.69 $473,884 - $677,764
183,676 Added 161.61%
297,329 $868,000
Q1 2024

May 15, 2024

SELL
$1.46 - $3.97 $87,451 - $237,795
-59,898 Reduced 34.51%
113,653 $413,000
Q4 2023

Feb 14, 2024

BUY
$0.96 - $1.53 $156,995 - $250,211
163,537 Added 1633.08%
173,551 $262,000
Q3 2023

Nov 14, 2023

SELL
$1.26 - $2.1 $30,463 - $50,771
-24,177 Reduced 70.71%
10,014 $13,000
Q2 2023

Aug 14, 2023

SELL
$1.56 - $1.84 $345,430 - $407,431
-221,430 Reduced 86.62%
34,191 $61,000
Q1 2023

May 15, 2023

BUY
$1.6 - $2.48 $156,163 - $242,052
97,602 Added 61.77%
255,621 $424,000
Q4 2022

Feb 14, 2023

BUY
$1.68 - $2.5 $1,406 - $2,092
837 Added 0.53%
158,019 $303,000
Q3 2022

Nov 14, 2022

SELL
$0.29 - $4.04 $10,265 - $143,011
-35,399 Reduced 18.38%
157,182 $352,000
Q2 2022

Aug 16, 2022

BUY
$3.24 - $5.85 $545,029 - $984,081
168,219 Added 690.5%
192,581 $624,000
Q1 2022

May 17, 2022

BUY
$4.6 - $8.83 $14,121 - $27,108
3,070 Added 14.42%
24,362 $128,000
Q4 2021

Feb 15, 2022

BUY
$7.75 - $10.05 $4,975 - $6,452
642 Added 3.11%
21,292 $181,000
Q3 2021

Nov 16, 2021

BUY
$7.78 - $10.0 $59,727 - $76,770
7,677 Added 59.18%
20,650 $205,000
Q2 2021

Aug 16, 2021

SELL
$9.22 - $14.48 $35,635 - $55,965
-3,865 Reduced 22.95%
12,973 $121,000
Q1 2021

May 18, 2021

BUY
$9.0 - $14.57 $151,542 - $245,329
16,838 New
16,838 $176,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $571M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.